• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在有和没有 COPD 的老年人中,表达 FEV1 和死亡率的替代方法。

Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD.

机构信息

Area di Geriatria, Università Campus Biomedico, Rome, Italy.

出版信息

Eur Respir J. 2013 Apr;41(4):800-5. doi: 10.1183/09031936.00008812. Epub 2012 Jul 12.

DOI:10.1183/09031936.00008812
PMID:22790922
Abstract

Expressing forced expiratory volume in 1 s (FEV1) as % predicted relies on the assumption of proportional variability and generalisability of prediction equations that may be unrealistic, especially for elderly people. We evaluated the prognostic implications of alternative ways of expressing FEV1. We enrolled 318 patients with chronic obstructive pulmonary disease (COPD) and 475 controls in the Salute Respiratoria nell'Anziano (SARA) study. The risk for 5-, 10- and 15-year mortality associated with FEV1 was studied by expressing FEV1 % pred, standardised by height cubed (FEV1 · Ht(-3)) and as a multiple of the sex-specific first percentile (FEV1 quotient (FEV1Q)). In the group with COPD, the incidence rate ratio for the worst versus the best quintile of FEV1Q was 4.65 (95% CI 2.33-10.37), compared to 2.98 (1.53-6.27) for FEV1 % pred and 3.95 (2.01-8.45) for FEV1 · Ht(-3). The corresponding incidence rate ratios at 15 years were 4.52 (2.84-7.43), 3.16 (2.02-5.07) and 3.52 (2.25-5.63), respectively. In the control group, even moderate reduction of FEV1Q was associated with long-term mortality, while FEV1 % pred was not associated with the outcome. FEV1Q may be more informative about prognosis in an elderly population compared to FEV1 % pred.

摘要

将 1 秒用力呼气量(FEV1)表达为预计值的%依赖于预测方程的比例可变性和通用性的假设,这在老年人中可能不现实。我们评估了表达 FEV1 的替代方法的预后意义。我们招募了慢性阻塞性肺疾病(COPD)患者 318 例和对照 475 例进行 Salute Respiratoria nell'Anziano(SARA)研究。通过表达 FEV1 % pred、按身高立方(FEV1 · Ht(-3))标准化和作为性别特异性第一百分位数的倍数(FEV1 商(FEV1Q))来研究 FEV1 与 5、10 和 15 年死亡率的相关性。在 COPD 组中,FEV1Q 最差与最佳五分位数的发生率比为 4.65(95%CI 2.33-10.37),而 FEV1 % pred 为 2.98(1.53-6.27),FEV1 · Ht(-3) 为 3.95(2.01-8.45)。相应的 15 年发生率比分别为 4.52(2.84-7.43)、3.16(2.02-5.07)和 3.52(2.25-5.63)。在对照组中,即使 FEV1Q 中度降低也与长期死亡率相关,而 FEV1 % pred 与结果无关。与 FEV1 % pred 相比,FEV1Q 可能更能提供关于老年人群预后的信息。

相似文献

1
Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD.在有和没有 COPD 的老年人中,表达 FEV1 和死亡率的替代方法。
Eur Respir J. 2013 Apr;41(4):800-5. doi: 10.1183/09031936.00008812. Epub 2012 Jul 12.
2
Alternative ways of expressing forced expiratory volume in the first second and long-term mortality in elderly patients with asthma.在哮喘老年患者中,用其他方式表达第一秒用力呼气量与长期死亡率的关系。
Ann Allergy Asthma Immunol. 2013 Nov;111(5):382-6. doi: 10.1016/j.anai.2013.08.013. Epub 2013 Sep 10.
3
A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.一项基于医院的关于慢性阻塞性肺疾病及其他疾病患者肺功能测试和运动耐量的研究。
J Indian Med Assoc. 2007 Oct;105(10):565-6, 568, 570 passim.
4
Restrictive pulmonary dysfunction at spirometry and mortality in the elderly.老年人肺活量测定时的限制性肺功能障碍与死亡率
Respir Med. 2008 Sep;102(9):1349-54. doi: 10.1016/j.rmed.2008.02.021. Epub 2008 Jul 2.
5
Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study.六秒肺活量在慢性阻塞性肺疾病患者中的预后价值:一项队列研究
PLoS One. 2015 Oct 21;10(10):e0140855. doi: 10.1371/journal.pone.0140855. eCollection 2015.
6
Comparison of different staging methods for COPD in predicting outcomes.比较不同分期方法在预测 COPD 结局中的作用。
Eur Respir J. 2018 Mar 15;51(3). doi: 10.1183/13993003.00577-2017. Print 2018 Mar.
7
Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.慢性阻塞性肺疾病严重程度对非紧急冠状动脉旁路移植术患者手术结局的影响。
Eur J Cardiothorac Surg. 2012 Jul;42(1):108-13; discussion 113. doi: 10.1093/ejcts/ezr271. Epub 2012 Jan 22.
8
Longitudinal assessment in COPD patients: multidimensional variability and outcomes.COPD 患者的纵向评估:多维变异性和结局。
Eur Respir J. 2014 Mar;43(3):745-53. doi: 10.1183/09031936.00096913. Epub 2013 Sep 26.
9
Predictive Value of Different Expressions of Forced Expiratory Volume in 1 Second (FEV1) for Adverse Outcomes in a Cohort of Adults Aged 80 and Older.1秒用力呼气量(FEV1)不同表达对80岁及以上成年人群不良结局的预测价值
J Am Med Dir Assoc. 2017 Feb 1;18(2):123-130. doi: 10.1016/j.jamda.2016.08.012. Epub 2016 Oct 14.
10
[Pulmonary function in first generation children of chronic obstructive pulmonary disease (COPD) patients: assessment of related predicting factors].[慢性阻塞性肺疾病(COPD)患者第一代子女的肺功能:相关预测因素评估]
Zhonghua Yi Xue Za Zhi. 2002 Aug 25;82(16):1136-9.

引用本文的文献

1
An updated comparison of standard and novel FEV1 indices' association with all-cause mortality.标准和新型第一秒用力呼气量(FEV1)指标与全因死亡率关联的最新比较
PLoS One. 2025 May 15;20(5):e0323681. doi: 10.1371/journal.pone.0323681. eCollection 2025.
2
Pulmonary function as a continuum of risk: critical care utilization and survival after allogeneic hematopoietic stem cell transplantation - a multicenter cohort study.肺功能作为风险的连续体:异基因造血干细胞移植后重症监护的利用和生存率 - 一项多中心队列研究。
Bone Marrow Transplant. 2024 Jul;59(7):942-949. doi: 10.1038/s41409-024-02265-8. Epub 2024 Mar 16.
3
FEVQ: a race-neutral approach to assessing lung function.
FEVQ:一种评估肺功能的种族中立方法。
Eur Respir J. 2024 Apr 4;63(4). doi: 10.1183/13993003.01622-2023. Print 2024 Apr.
4
Can spirometry improve the performance of cardiovascular risk model in high-risk Eastern European countries?在东欧高危国家,肺功能测定能否改善心血管风险模型的性能?
Front Cardiovasc Med. 2023 Aug 29;10:1228807. doi: 10.3389/fcvm.2023.1228807. eCollection 2023.
5
Truth and Consequences: Choosing the Best Interpretative Framework for Spirometry.真相与后果:为肺功能测定选择最佳解释框架
Am J Respir Crit Care Med. 2024 Jan 1;209(1):6-7. doi: 10.1164/rccm.202308-1493ED.
6
Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement.肺功能测试解读中的种族和民族差异:美国胸科学会官方声明。
Am J Respir Crit Care Med. 2023 Apr 15;207(8):978-995. doi: 10.1164/rccm.202302-0310ST.
7
A reply to questions raised about FEVQ and bronchodilator responsiveness.对有关 FEVQ 和支气管扩张剂反应性的问题的答复。
Eur Respir J. 2023 Jan 19;61(1). doi: 10.1183/13993003.02025-2022. Print 2023 Jan.
8
Influences of Two FEV Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD Patients.两种 FEV 参考方程(GLI-2012 和 GIRH-2017)对 COPD 患者气流受限分类的影响。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 2;17:2053-2065. doi: 10.2147/COPD.S373834. eCollection 2022.
9
All-cause and cardiovascular mortality in relation to lung function in the full range of distribution across four Eastern European cohorts.在四个东欧队列中,在整个分布范围内,与肺功能相关的全因和心血管死亡率。
Sci Rep. 2022 Jul 28;12(1):12959. doi: 10.1038/s41598-022-17261-5.
10
How to Stage Airflow Limitation in Stable Chronic Obstructive Pulmonary Disease Male Patients?如何对稳定期慢性阻塞性肺疾病男性患者进行气流受限分级?
Am J Mens Health. 2020 May-Jun;14(3):1557988320922630. doi: 10.1177/1557988320922630.